Research Program Research Articles

Identification and analysis of microplastics in para-tumor and tumor of human prostate

While microplastics are widely found in various human organs and tissues, the relationship between microplastics and human health, especially prostate health, remains unclear. This study aims to identify and quantify the properties, types, and abundance of microplastics in paired para-tumor and tumor tissues of human prostate. Additionally, the potential correlation between microplastics abundance and prostate cancer are investigated. Paired para-tumor and tumor samples of the prostate were collected from 22 patients who underwent robot-assisted radical prostatectomy. A combination of laser direct infrared spectroscopy, scanning electron microscopy and pyrolysis-gas chromatography-mass spectrometry was utilized to analyse the properties, type and abundance of microplastics. Correlations between microplastics abundance, demographic characteristics and clinical features of patients were also examined. Laser direct infrared analysis revealed the presence of microplastics, including polyamide, polyethylene terephthalate, and polyvinyl chloride, in both para-tumor and tumor tissues of human prostate. However, polystyrene was exclusively detected in tumor tissues. The particle size distribution in the prostate tissue mainly ranged from 20 to 100μm. Approximately 31.58% of para-tumor samples exhibited sizes between 20 and 30μm, while 35.21% of tumor samples displayed sizes between 50 and 100μm. The shapes of these microplastics varied considerably with irregular forms being predominant. Additionally, microplastics were detected by pyrolysis-gas chromatography-mass spectrometry in 20 paired prostate tissues. The mean abundance of microplastics was found to be 181.0μg/g and 290.3μg/g in para-tumor and tumor of human prostate samples, respectively. Among the 11 target types microplastics polymers, only polystyrene, polypropylene, polyethylene, and polyvinyl chloride were detected. Notably, polystyrene, polyethylene, and polyvinyl chloride, except for polypropylene, demonstrated significantly higher abundance in tumor tissues compared to their respective paired para-tumor. Furthermore, a positive correlation was observed between polystyrene abundance in the tumor samples of human prostate and frequency of take-out food consumption. This research provides both qualitative and quantitative evidence of the microplastics presence as well as their properties, types, and abundance in paired para-tumor and tumor samples of human prostate. Correlations between microplastics abundance, demographics, and clinical characteristics of patients need to be further validated in future studies with a larger sample size. This work was supported by the National Key Research and Development Program of China (2022YFC2702600) and the National Natural Science Foundation of China (Grant No. 82071698, No. 82101676, and No. 82271630).

PEPR DIADEM: Priority Equipment and Research Program on the development of innovative materials using artificial intelligence

IntroductionThe quest to develop efficient, sustainable materials from non-critical, non-toxic resources is one of today's most formidable challenges in the current context of energy, transport, digital or healthcare transitions. In response, France launched the pioneering Priority Equipment and Research Program (PEPR) DIADEM in 2022. This innovative initiative, focused on DIscovery Acceleration for the Deployment of Emerging Materials (DIADEM), leverages Artificial Intelligence (AI) to accelerate the innovation chain from conception to realization, revolutionizing Materials Science sustainably.With a strategic emphasis on scientific synergy, PEPR DIADEM aims to expedite the discovery and development of novel materials essential for contemporary and future societal challenges. To achieve this, the program seeks to catalyze breakthroughs in areas ranging from energy efficiency to transportation, digitalization, and healthcare, covering a broad spectrum of materials from metallic alloys to functional nanostructures.Aligned with the Green Deal framework's ambitious targets, PEPR DIADEM addresses the urgent need for accelerated sustainable materials research. By utilizing cutting-edge technologies like rapid synthesis and characterization tools, automation, digital simulations, data management, AI, additive manufacturing, and thin film engineering, the program is set to significantly reshape the materials science landscape.As PEPR DIADEM embarks on its journey of innovation, it not only advances scientific knowledge but also holds the promise of addressing current global challenges and paving the way for a more sustainable and prosperous future.

Мир объективного знания и социально-экономическая реальность (К. Поппер & К. Маркс)

The growing specialization and formalization of economic knowledge threatens to break away from the general scientific base that forms the worldview of the researcher. An urgent task is presented in the reintegration of basic methodological principles and categories of science into modern social science and economic theory. The article conducts a comparative analysis of the works of K. Marx and K. Popper, who made revolutionary changes in the methodology and ideological attitudes (conceptual frameworks) of scientific knowledge. Marx’s contribution focuses on dialectical and historical materialism, the doctrine of the economic basis of society and the change of socio-economic formations; Popper’s contribution focuses on his trial and error method with falsifying interpretation of results and the concept of successive three worlds of the universe. Popper’s criticisms of Marxist doctrine (essentialism, elements of mythology, teleologism) and the counterarguments of consistent Marxists are evaluated. The paper characterizes Popper’s positions on the realism of scientific knowledge, the world of predispositions, flexible management in animate and inanimate nature, the world of mental states of consciousness and the world of the objective content of thinking. Their commonality with the provisions of dialectical and historical materialism (the material nature of objective reality, the theory of reflection, the role of objective mental forms and ideological social relations) in the formation of the ‘world of objective knowledge’ is shown. The insufficiency of Popper’s epistemology for the study of the economic basis of social life is revealed. Based on a structural and logical analysis of the methodological principles and theoretical positions of Marx and Popper, the paper outlines the paths to the development of a system of concepts that brings together the complementary results of their apparently opposing research programs. Also presented are sources showing the relevance of the ideas of Marx and Popper in modern methodological and socio-economic literature. It is concluded that the world of objective knowledge (the key category of Popper’s social science) is part of the socio-economic life of society (in its Marxist interpretation), which, in turn, is incomplete without taking into account the realities of this world and needs additional study from the appropriate angle.

Consumer likelihood to purchase farmed marine finfish with potential for commercialization in the United States

Local aquaculture production of marine finfish has potential to meet the domestic seafood demand and contribute to reduction of the United States (U.S.) seafood trade deficit. The United States Department of Agriculture-Agricultural Research Service, along with other research programs, has developed aquaculture production technologies for warmwater marine finfish species with potential for commercial production. To understand the marketing opportunities for the candidate species, an online survey of 818 seafood consumers in the southeastern U.S. was conducted to explore their awareness, familiarity, frequency of consumption, location of purchase, and likelihood of purchasing the species of interest. A binary logit model was specified to explore the factors that influenced consumers likelihood to purchase Atlantic cod, black sea bass, California flounder, California yellowtail, Florida pompano, redfish, red snapper, southern flounder, spotted seatrout, striped bass, summer flounder, and white seabass, the 12 species for which there were at least 100 survey responses. This study focused on consumers likelihood to purchase the candidate species at grocery stores and restaurants. The results show that consumers who placed high importance on source of the fish and quality were more likely to buy various candidate species including red snapper, striped bass, Atlantic cod, southern flounder, Florida pompano, California yellowtail, black sea bass, California flounder, and white seabass. Respondents who considered price to be important were more likely to buy California flounder, redfish, red snapper, white seabass, black sea bass (at grocery stores only), and summer flounder (at grocery stores only). Frequent consumers of Atlantic cod, southern flounder, California flounder, redfish, summer flounder (at grocery stores only) and California yellowtail (at grocery stores only) were more likely to purchase these species. Frequency of consumption, seasonality in consumption, and demographic characteristics, including income, age, race, and state of residence, influenced consumers likelihood to purchase various species of interest.

Abatement of the Survival Cliff in Older Adolescents and Young Adults with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma in the United States.

Purpose: In 2018, a "survival cliff" in the United States was identified among older adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL). This study reassessed the cliff and associated putative causes. Methods: Survival data were obtained using the U.S. Surveillance Research Program, National Cancer Institute (NCI) SEER 22 Registries. Accrual data on cancer treatment trials conducted by the NCI cooperative groups and NCI-designated cancer centers were obtained from the NCI Cancer Therapy Evaluation Program. Trend and average percent changes and statistical significances were identified with the NCI Joinpoint Regression Program. Results: A previous cliff-like decrement in the survival of 17- to 20-year-olds is no longer apparent, overall and in all racial and ethnic groups. The "survival cliff" age range was coincident with a clinical trial accrual cliff, and both diminished when more clinical trials were available to, and participated in by, young adult patients. Older AYA patients of ages 30-39 had minimal improvement in clinical trial accrual and least survival gain among the AYA age group. Conclusion: The survival cliff has abated, resulting in thousands of fewer premature deaths and tens of thousands of years of life saved-a remarkable achievement. The survival improvement may be attributed to improved clinical trial availability for and recruitment and participation of AYAs on treatment trials, application of pediatric-inspired ALL treatment regimens to AYAs, expanded national health insurance for -18 to 25 year olds, improved AYA cancer services, and a national focus on AYA oncology.

Cleavages and identities in the changing landscape of world politics

The article advocates updating the research concerning divided societies and complexly organized states. It addresses the genesis and advancement of complex identities of social actors and political agency. The discussion focuses on the correlation between the structuration and content saturation of identities. The use of operational interfaces from fundamental distinctions to various kinds of divides, demarcations and polarizations leaves still unresolved the problem of qualitative parameters of identities, and ways to represent and analyze them. Innovative approaches developed by Russian political scientists take into account the relationship between the processes of world development and the identity of its development drivers and agency from individual political actors to complex social movements. The article shows that the effective deployment of the respective research program requires not only external accounting of the temporal parameters, but full integration of modern evolutionary approaches into their methodology. It is necessary to overcome the usual interpretations of identity in the singular as an abstract universal idea. Equally it is necessary to move to the study of the complex interaction of the acting forces of development and the formation of a dynamic flow of individual and mutual identifications in the plural. To this end, it is suggested not only to update the Rokkanian paradigm of demarcations by expanding the set of distinctions and making the whole structure more dynamic, but also to use the possibilities of extended evolutionary synthesis.

A Comment on the Scientific and Technological Development Strategy of the Russian Federation

The article discusses the text of the Scientific and Technological Development Strategy of Russia approved in early 2024. The author notes that it was prepared in accordance with the Federal Law “On Strategic Planning in the Russian Federation” of June 28, 2014, No. 172-FZ. The Strategy replaces a number of documents that have been adopted earlier. The expert community have different opinions on the preparation quality of concepts, strategies, programs and other strategic documents being approved. The reason lies in the absence of a clear system and hierarchy of strategic planning documents. In the Strategy under discussion, there is a vagueness of the used conceptual framework and some shortcomings in the analytical part of the document. In addition, the authors of the Strategy connect the issues of the development of the science and technology sector in the Russian Federation mainly with external challenges and threats and pay less attention to internal problems caused primarily by the inefficiency of the R&D management system, insufficient financing and a low proportion of private funding. It is shown that no significant changes are expected in the management system of scientific and technological development in Russia in the next decade. We can welcome the establishment of the Science and Technology Council of the Commission for Scientific and Technological Development of the Russian Federation under the Russian Government and its machinery and the introduction of the model of “qualified customer”, as well as the use of new tools: long-term fundamental academic research programs and programs of scientific and technological development of Russia. But the discussed Strategy does not pay enough attention to the issues of education and training of research and engineering personnel.

Is eHealth Research with or on Our People?: Lessons Learned Using the Aboriginal and Torres Strait Islander Quality Appraisal Tool.

There is growing evidence for the benefits of eHealth interventions with Aboriginal and Torres Strait Islander people. Yet, there is a lack of guidance for culturally safe, relevant, and sustainable initiatives with Aboriginal and Torres Strait Islander peoples and organisations. To this end a research program was established to develop a roadmap for eHealth with Aboriginal and Torres Strait Islander peoples. The current phase of the research program is a review of the literature aimed at identifying the important characteristics of eHealth interventions with Aboriginal and Torres Strait Islander people. Thirty-nine publications reporting on a variety of eHealth modalities with Aboriginal and Torres Strait Islander people were identified. To assess the cultural quality of the final papers, the authorship applied the Aboriginal and Torres Strait Islander Quality Appraisal Tool (QAT). Results from the appraisal demonstrated significantly higher QAT scores between studies, including more Indigenous authors. This further substantiates the importance Aboriginal and Torres Strait Islander ways of knowing, doing, and being incorporating Indigenous worldviews and leadership have on the cultural quality of eHealth research studies.

Innovations in recycled construction materials: paving the way towards sustainable road infrastructure

The expansive development of infrastructure has led to increased consumption of virgin aggregates in road construction, resulting in significant environmental impacts. To address this issue, there is a pressing need for sustainable alternatives that utilize recycled materials in pavement applications. This paper presents a comprehensive review of a decade-long research program focused on the development and evaluation of sustainable pavement materials, such as recycled and waste aggregates, industrial by-products, and natural fibers. The research encompassed a wide range of innovative materials and technologies, such as geopolymer-stabilized recycled aggregates, cement-stabilized waste materials, natural additive-modified cement stabilization, and recycled aggregate-geogrid reinforcement systems. The experimental framework employed a combination of mechanical testing, durability assessment, microstructural analysis, and environmental safety evaluation to assess the performance and sustainability of these materials. The key findings demonstrated the superior mechanical properties, improved durability, and environmental suitability of the recycled materials compared to conventional virgin aggregates. The successful implementation of these sustainable solutions in real-world projects highlights their potential to reduce the environmental footprint of road infrastructure development. Furthermore, the paper discussed the practical implications of the research outcomes for pavement design and construction, as well as future research directions to further advance the field of sustainable pavement engineering. The findings of this research report can be used as guidance for researchers, practitioners, and policymakers seeking to upcycle the widespread adoption of recycled materials in road application and contribute to the development of a more sustainable and resilient transportation infrastructure.

Integrated clinical risk prediction of type 2 diabetes with a multifactorial polygenic risk score.

Combining information from multiple GWASs for a disease and its risk factors has proven a powerful approach for development of polygenic risk scores (PRSs). This may be particularly useful for type 2 diabetes (T2D), a highly polygenic and heterogeneous disease where the additional predictive value of a PRS is unclear. Here, we use a meta-scoring approach to develop a metaPRS for T2D that incorporated genome-wide associations from both European and non-European genetic ancestries and T2D risk factors. We evaluated the performance of this metaPRS and benchmarked it against existing genome-wide PRS in 620,059 participants and 50,572 T2D cases amongst six diverse genetic ancestries from UK Biobank, INTERVAL, the All of Us Research Program, and the Singapore Multi-Ethnic Cohort. We show that our metaPRS was the most powerful PRS for predicting T2D in European population-based cohorts and had comparable performance to the top ancestry-specific PRS, highlighting its transferability. In UK Biobank, we show the metaPRS had stronger predictive power for 10-year risk than all individual risk factors apart from BMI and biomarkers of dysglycemia. The metaPRS modestly improved T2D risk stratification of QDiabetes risk scores for 10-year risk prediction, particularly when prioritising individuals for blood tests of dysglycemia. Overall, we present a highly predictive and transferrable PRS for T2D and demonstrate that the potential for PRS to incrementally improve T2D risk prediction when incorporated into UK guideline-recommended screening and risk prediction with a clinical risk score.

Mentorship in health research institutions in Africa: A systematic review of approaches, benefits, successes, gaps and challenges.

In Africa, where the burden of diseases is disproportionately high, significant challenges arise from a shortage of skilled researchers, lack of research funding, and limited mentorship opportunities. The continent faces a substantial gap in research output largely attributed to the dearth of mentorship opportunities for early career researchers. To explore existing mentorship approaches, identify challenges, gaps, successes, and benefits, and provide insights for strengthening mentorship programs in African health research institutions. We registered the review protocol on the International Prospective Register of Systematic Reviews [CRD42021285018] and searched six electronic databases-EMBASE, AJOL, Web of Science, PubMed, DOAJ, and JSTOR from inception to 10 November 2023, for studies published in English reporting on approaches of mentorship in health research in African countries. We also searched grey literature repositories, institutional websites, and reference lists of included studies for additional literature. Two independent reviewers conducted screening of titles and abstracts of identified studies, full-text screening, assessment of methodological quality, and data extraction. We assessed study quality against the Mixed Methods Appraisal Tool (MMAT). We resolved any disagreements through discussion and consensus. We employed a narrative approach to synthesize the findings. We retrieved 1799 articles and after screening, included 21 studies in the review. The reviewers identified 20 mentorship programs for health researchers (N = 1198) in 12 African countries mostly focusing on early-career researchers and junior faculty members. A few included mid-career and senior researchers. We categorized the programs under three key mentoring approaches: international collaborative programs, regional and in-country collaborations, and specialized capacity-building initiatives. Our review highlighted the following successes and benefits of health research mentorship programs: the establishment of collaborations and partnerships, development of research programs and capacities, improvement of individual skills and confidence, increased publications, and successful grant applications. The gaps identified were limited funding, lack of a mentorship culture, negative attitudes towards research careers, and lack of prioritization of research mentorship. Our review highlights a diverse landscape of health research mentorship aspects predominantly targeting early career researchers and heavily driven by the North. There is a need for locally driven mentorship initiatives in Africa to strengthen mentorship to advance health research in the region. PROSPERO registration number: CRD42021285018.

Beneficiaries in the EU framework programs for research and innovation («Horizon 2020», «Horizon Europe»), European structural and investment funds

Problem setting. Nowadays, the issue of obtaining funding for scientific research, scientific and technical (experimental) developments is increasingly important. This practice is common, for example, in the EU. Many sources are offered: EU Framework Programs for Research and Innovation, European Structural and Investment Funds, etc. However, to understand the financing procedure itself, it is necessary to have some knowledge, including regarding EU legislation. First of all, attention should be focused on the terms, because this is the foundation, the alphabet. One of them is the beneficiary. It is found in many EU legal acts, but does not always have a fixed definition. Analysis of recent researches and publications. The main goal of the program or fund is to receive project funding. Foreign scholars focus their research in this area (for example, Mario J. Al Sayah, Pierre-Antoine Versini, Daniel Schertzer, Olatz Ukar Arrien, Marta Enciso-Santocildes). This situation is due to the fact that they have more modern and updated research infrastructures than Ukraine. Terms remain beyond their attention. However, there are isolated works with only the mention of the term in the issue without any analysis of it (for example, Glybko S., Kokhan V.). Purpose of the research is to clarify the term «beneficiary» in the EU Framework Programs for Research and Innovation, European Structural and Investment Funds. Article’s main body. An attempt is made to conduct a comparative analysis of the considered term in the EU Framework Programs for Research and Innovation («Horizon 2020», «Horizon Europe») and the European Structural and Investment Funds. Each of them has its own EU legal framework. However, only Regulation (EU) № 1303/2013 of the European Parliament and of the Council of 17 December 2013 laying down common provisions on the European Regional Development Fund, the European Social Fund, the Cohesion Fund, the European Agricultural Fund for Rural Development and the European Maritime and Fisheries Fund and laying down general provisions on the European Regional Development Fund, the European Social Fund, the Cohesion Fund and the European Maritime and Fisheries Fund and repealing Council Regulation (EC) № 1083/2006, defines the term «beneficiary». Regulation (EU) 2021/695 of the European Parliament and of the Council of 28 April 2021 establishing Horizon Europe – the Framework Programme for Research and Innovation, laying down its rules for participation and dissemination, and repealing Regulations (EU) № 1290/2013 and (EU) № 1291/2013 refers to Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council of 18 July 2018 on the financial rules applicable to the general budget of the Union, amending Regulations (EU) № 1296/2013, (EU) № 1301/2013, (EU) № 1303/2013, (EU) № 1304/2013, (EU) № 1309/2013, (EU) № 1316/2013, (EU) No 223/2014, (EU) № 283/2014, and Decision № 541/2014/EU and repealing Regulation (EU, Euratom) No 966/2012, which defines the term «beneficiary». The EU Framework Programmes for Research and Innovation («Horizon 2020», «Horizon Europe») contain definitions of the types of beneficiary. It is the target final beneficiary and beneficiary of the Accelerator. The possibility of achieving synergy between the specified programs and the European Structural and Investment Funds is being investigated, if there are already differences regarding the definition of the term «beneficiary». Conclusions and prospects for the development. The author states the following conclusions according to the obtained results: EU legal acts do not contain a single vision for the same term «beneficiary». We believe that it is necessary to review this situation in order to achieve the synergy established in the Regulations (EU).

Abstract B149: Investigating Disparities in Cost-Associated Barriers to Medication Adherence in Breast Cancer Survivors in the National Institutes of Health All of Us Research Program

Abstract Purpose: Medication adherence (e.g., endocrine therapy, antihypertensives) during survivorship remains suboptimal. Racial disparities in medication adherence continue to persist, yet reasons for this disparity are not fully understood. This study aimed to assess racial differences in cost-associated barriers to medication adherence. Methods: This cross-sectional analysis utilized data from the National Institutes of Health All of Us Research Program. Cohort eligibility included identifying as Black/African American or White, being at least 18 years old, and having a diagnosis of breast cancer. Survivors must have completed the Healthcare Access and Utilization survey, a validated assessment of factors impacting healthcare behaviors. Comparisons between patient characteristics (e.g., age, annual income, marital status, employment, education, etc.) and survey responses were analyzed by race using Pearson’s chi-square tests. Univariable and multivariable logistic regression models were fitted to investigate the unadjusted and adjusted associations of cost-related barriers to medication adherence and race. Results: Among the 1,840 breast cancer survivors included in this cohort, the mean age was 63.8 (standard deviation (sd) = 10.4). The majority of survivors were White (94.3%) (5.7% Black), married (58.9%) and unemployed (57.4%). The mean score for racial discrimination in healthcare was 10.3 (sd = 3.8) (range = 7 - 35). Most survivors did not report any cost-related barriers to adherence (74.9%); however, 19.5% of survivors asked their doctor for lower cost medication to save money. When compared with White survivors, a higher proportion of Black survivors reported that they could not afford prescription medicines (6.5% vs. 12.4%). In the multivariable model, no significant association by race was observed (p=0.387). Survivors who reported annual household income levels above $50k were less likely to report cost-reported barriers when compared to survivors who reported a household income of <$25k (p<0.001). Each one-point increase in perceived discrimination in healthcare increased the odds of reporting a cost-related barrier to adherence by a factor of 1.10 (95% confidence interval: 1.07, 1.13). Conclusions: Although racial differences were not noted for overall cost-related barriers, results highlight a need to understand nuanced differences in perceived cost-related barriers to adherence and how survivors navigate those differences. Further research is needed to understand providers’ roles in encouraging medication adherence and how discrimination in healthcare may serve as a barrier to adherence. Citation Format: Arnethea L. Sutton, Jian He, Lakeshia Cousin, Keesha Powell-Roach, Mandy J. Hill, Wendy Bottinor. Investigating Disparities in Cost-Associated Barriers to Medication Adherence in Breast Cancer Survivors in the National Institutes of Health All of Us Research Program [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr B149.

Abstract B170: Advancing cancer disparities research through the integration of new data: Opportunities from the National Institutes of Health All of Us Research Program

Abstract The NIH All of Us Research Program is building one of the largest, richest, and most diverse health datasets of its kind. The program aims to promote health equity across multiple health conditions including cancer by making a comprehensive and diverse dataset available to over 10,000 vetted and registered researchers on its Researcher Workbench (RW). The RW offers access to various data types including genomics, electronic health records, physical measurements, wearable data, and survey data on social determinants of health (SDOH) and self- reported cancer diagnoses. The latest data release (Q3 2024), also known as the Curated Data Repository (CDR Version 8) includes data from over 630,000 participants, with more than 80% from populations underrepresented in biomedical research (UBR). Racial, ethnic minoritized populations and other underrepresented groups are more likely to experience health-related disparities and inequities. While previous data releases included aggregate categories, new data released in CDR Version 8 considers the interplay of self-identified categories of demographic descriptors and allows the examination of comorbidities, while emphasizing the importance of identifying appropriate comparator groups in research and considering the heterogeneity that exists within and across groups. It includes a 40% increase in array data, a 67% increase in srWGS data, and a 150% increase in long-read sequences, as well as data from expanded EHR sources, DHT devices, a new Life Functioning Survey, and racial and ethnic subcategories for more than 610,000 participants. This vast and diverse dataset release enables the examination of the intersecting impact of SDOH on cancer-related outcomes both within and across racial and ethnic populations, including populations experiencing health-related disparities and inequities. The extensive data release is facilitated by a two-pronged approach: A robust community and participant engagement model and the All of Us Health Equity strategic plan (HESP). The program employs a socioecological model for participant recruitment and retention, specifically targeting UBR groups. This multi-level approach encompasses activities ranging from targeted outreach and awareness campaigns to establishing trust and fostering collaborative partnerships with communities and participants. HESP complements these efforts by promoting the integration of equity considerations across the research lifecycle through the promotion of data equity and data justice. This community engagement and equity integrated approach guarantees that participants who reflect the demographic diversity of cancer patients in the United States and territories are actively engaged in shaping and benefiting from cancer disparities research. This session will update the scientific audience on recent data expansions available to researchers, provide examples of how that data can be used to examine disparities in cancer outcomes and prevention, and demonstrate the importance of community engagement and health equity in advancing research. Citation Format: Karriem S Watson, JoAnn Smith, Nandita Rahman, Ryan Lupi, Rubin Baskir, Romuladus Azuine, Janeth Sanchez. Advancing cancer disparities research through the integration of new data: Opportunities from the National Institutes of Health All of Us Research Program [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr B170.

Abstract A052: The association of perceived neighborhood environment with physical and mental health status among cancer survivors in the All of Us Research Program

Abstract Background Neighborhood environment has been recognized as a key determinant of health. Neighborhood disorder refers to physical and social characteristics of neighborhoods that may signal the breakdown of order and social control. Previous studies have reported that neighborhood disorder, such as high levels of noise, vandalism, abandoned buildings, crime, and drug and alcohol use, is associated with poor self-reported health. In contrast, neighborhood social cohesion and the extent of connectedness in society have positive effects on physical and mental health. Little studies, however, have comprehensively examined the association between perceived neighborhood environment and health outcomes among cancer survivors. We examined and found this significant association among cancer survivors. Method We used survey and electronic health records data on cancer survivors aged ≥18 years (N=10,051) from All of Us Controlled Tier Dataset v7 (summer 2017-July 2022), including survey data on 21 items about neighborhood environment, neighborhood order, disorder, and social cohesion. Eleven items were used to measure perceived neighborhood disorder, six items were used to measure perceived neighborhood order, and four items were used to measure perceived social cohesion. Logistic regression models were used to estimate the association between each measure of neighborhood order, disorder, or social cohesion and physical and mental health status (poor/fair versus very good/excellent), adjusted for 1) age and sex; 2) age, sex, race/ethnicity, educational attainment, annual household income, employment, health insurance, marital status, living alone, house ownership, nativity, smoking, and heavy alcohol drinking. Results Cancer survivors living in neighborhoods with high level of order and social cohesion were less likely to report poor or fair physical health. For example, cancer survivors who perceived their neighborhood as sharing the same values were less likely to report poor or fair physical health (OR=0.49; 95% CI=0.39- 0.61). Additionally, cancer survivors who felt their neighborhood was safe were less likely to report poor or fair physical health (OR=0.71; 95% CI=0.55-0.92). In contrast, cancer survivors residing in neighborhood with disorder characteristics were more likely to report poor or fair physical health. Specifically, those living in neighborhood with common vandalism were more likely to report poor or fair physical health (OR=1.40; 95% CI=1.08-1.80). Furthermore, cancer survivors who perceived high level of drug use in their neighborhood were more likely to report poor or fair physical health (OR=1.49; 95% CI=1.19-1.88). Similar associations were observed between 19 neighborhood characteristics and mental health status. Conclusions Most neighborhood characteristics evaluated in this study were associated with self-reported physical and mental health status among cancer survivors. These findings suggest that improving built environment and social support could enhance perceived health and quality of life in this population. Citation Format: Dongjun Lee, Farhad Islami, Ahmedin Jemal, Hyunjung Lee. The association of perceived neighborhood environment with physical and mental health status among cancer survivors in the All of Us Research Program [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr A052.

Abstract B014: Cannabis use among cancer survivors and its association with cardiometabolic risk factors: Findings from the All of Us Research Program

Abstract Purpose: Cannabis use has been linked to alleviating symptoms such as sleep issues, mental health, and physical problems resulting from cancer treatment among cancer survivors. However, in the US general population, evidence suggests that an increase in cannabis use increases the risk for cardiovascular disease including high blood pressure, type 2 diabetes, and high cholesterol. This is even more alarming since users who have been diagnosed with cancer have an even greater independent risk of cardiovascular events due to the toxicities of cancer therapeutic drugs. Given the US trend in cannabis legalization and decriminalization and the limited knowledge of the association between cannabis use and cardiometabolic biomarkers among cancer survivors, we aim to assess the independent associations between cannabis use and several cardiometabolic biomarkers and explore racial/ethnic and sex differences among a sample of cancer survivors from the All of Us (AoU) Program. Methods: Cross-sectional cannabis data and cardiometabolic risk factor biomarkers were obtained from adult cancer survivors in the AoU Research Program from 2018-2022. Cannabis use was defined as never use (in a lifetime or past three months), occasional use (twice or monthly in the past three months), and frequent/regular use (weekly or daily). Cardiometabolic outcomes included cardiovascular (e.g., systolic, diastolic blood pressure, hypertension), immune (i.e., White Blood Cell [WBC] counts, C-reactive protein [CRP]), and metabolic systems biomarkers (e.g. waist-to-hip ratio, lipids, HbA1c), were dichotomized from continuous values to elevated vs normal where high values, defined by clinically established cutoffs or >75th percentile, represented elevated biomarkers. Multivariable logistic regression and stratified models if interactions were statistically significant, adjusting for treatment, smoking, hazardous alcohol use, and sociodemographic variables were used. Results: Our cohort (N=6,985) consisted of 7.6% Hispanic, 6.2% Black, and 86.2% White survivors. Overall, 8.2% of survivors reported occasional and frequent/regular cannabis use, with Black survivors (9.7%) reporting a greater proportion of frequent/regular use compared to White (3.2%) and Hispanic (4.7%) survivors. Similarly, female (2.8%) survivors reported a lower frequency of frequent/regular cannabis use compared to male (4.2%) survivors. Compared to never users, frequent/regular users were 3.35(95% CI=1.10-10.53) times as likely to report elevated WBC count. No significant associations were found between cannabis use and CRP, cardiovascular, and metabolic systems biomarkers. Similarly, no race/ethnicity or sex (both pinteraction > 0.05) differences were found in the cannabis and WBC association. Conclusion: Our results underscore that more frequent cannabis use may have a detrimental effect on immune risk factors like WBC counts among survivors. Being that high WBC may be predictive of cardiovascular diseases and mortality, future studies should explore the longitudinal effects of cannabis use on WBC. Citation Format: Angel Arizpe, Claudia M. Toledo-Corral, Carol Y. Ochoa-Dominguez, Stephanie Navarro, Sue E. Kim, Albert J. Farias. Cannabis use among cancer survivors and its association with cardiometabolic risk factors: Findings from the All of Us Research Program [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr B014.

Abstract A103: Feasibility of using data from the All of Us Research Program to better understand Asian American breast cancer risk

Abstract Asian Americans (AAs) are the only racial/ethnic group in the United States for whom cancer is the leading cause of death. In AA women, the rate of breast cancer (BC) has significantly increased in the past two decades. However, the reasons behind the observed increase in risk are not well understood. The All of Us (AoU) Research Program aims to enroll one million participants nationwide, focusing on including individuals from diverse backgrounds, to advance precision health research. The goal of this pilot study was to evaluate the feasibility of using AoU data to analyze factors potentially associated with breast cancer risk in AAs and to develop enhanced breast cancer prediction models. There were 3,433 self-reported AA women with available genomic data. In addition to the genomic data, data was available from surveys, participants’ electronic health records (EHRs), and physical measurements taken at the time of their study visit. BC cases were identified by self-report on surveys (n=38), EHR diagnosis data (n=104), or both survey and EHR (n=59), totaling 201 cases identified. Of these, only 17 were incident cases. Of the 163 cases detected in the EHR, 96.3% were invasive BCs, and the median age at diagnosis was 54.2 (±12.6) years. Among the 38 survey-only-identified cases, age at diagnosis was unclear due to the large age ranges (e.g.18-64 years) in the categories presented in the survey. For purposes of the case-control analysis, five AA women with no BC diagnosis were matched to each BC case by age group and geographic region. Body mass index, annual household income, marital status, history of alcohol consumption, and history of cigarette smoking and vaping were not statistically significantly different between cases and controls (a=0.05). One third (34.3%) of cases were born in the U.S. and 65.2% were born in another country vs. 25.0% and 74.0% of controls, respectively (p= 0.01). Employment status was also different, with 50.8% of cases being unemployed vs. 42.0% of controls (p=0.02). There appeared to be a difference in first-degree family history of BC (reported in 8% of cases vs. 5% of controls) although the results were not statistically significant (p=0.08). However, family history of BC data was not available for 43.3% and 51.0% of the cases and controls, respectively. Gynecologic factors, such as ages at menarche and menopause, and hormone use, were not asked in the surveys and were not widely captured in the EHR data. In our analysis of nine BC- associated genes (BRCA1, BRCA2, ATM, TP53, PTEN, CHEK2, CDH1, PALB2, STK11), pathogenic variants were identified in 1.0% of cases and 0.7% of controls. In summary, the AoU data set enables the study of a diverse national cohort with rich genomic data. However, the low representation of AAs, small numbers of incident cases, limited data on personal gynecologic history, cancer family history and social determinants of health, and broad categorization of age at diagnosis present challenges to using this data to build accurate and effective risk prediction models for BC risk in AAs. Citation Format: Catalina Haas Garcia, Wen-Pin Chen, Danni Liu, Alice W Lee, Min Zhang, Argyrios Ziogas, Sora Tanjasiri, Hannah Lui Park. Feasibility of using data from the All of Us Research Program to better understand Asian American breast cancer risk [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr A103.

Asynchronous Literature Research Module for Undergraduate Engineering Research Program

This case study presents the development of an asynchronous online module for an engineering undergraduate research program. It includes an overview of the development of the literature research module in Qualtrics and its transition to the campus LMS, Canvas. Assessment of student learning is described. The benefits to librarians of this mode of instruction are also discussed. While aligning with the growing body of literature on asynchronous library instruction, this study demonstrates application of that modality through innovative instruction for a STEM extra-curricular program. It provides insights for instruction librarians looking to transition to asynchronous teaching.

Abstract B121: Enhancing opportunities for underrepresented minorities conducting cancer and cancer health disparities research nationwide: The Transformative Educational Advancement and Mentoring (TEAM) network

Abstract Background: The Transformative Educational Advancement and Mentoring (TEAM) network is a program funded by the Center to Reduce Cancer Health Disparities (CRCHD) of the National Cancer Institute (NCI). In support of the NCI’s goal to reduce cancer health disparities, the CRCHD drives workforce diversity efforts by supporting trainees from backgrounds underrepresented (UR) in cancer biomedical and behavioral sciences research. The two TEAM programs launched at minority-serving institutions (MSIs) in 2023: The Southwest TEAM (STEAM) network and San Diego State University’s (SDSU) Advancing Cancer Careers for ExceLlence (ACCEL). Each program has a unique model designed to best serve trainees in their respective regions, but both provide: 1) Diverse Training Champions (TCs), role models and navigators who act as the primary point of contact for scholars, provide direct services to trainees, ascertain member needs, develop programmatic offerings, and connect trainees to program components; 2) a mentorship program for pre and postdoctoral scholars and early stage investigators (ESIs); 3) targeted recruitment and professional development of UR scholars; and 4) tailored linkages to professional development and employment opportunities, and NCI/CRCHD funding priorities. This work summarizes the strategies planned across both programs to promote recruitment and retention of investigators from UR backgrounds and cultivate professional development opportunities for students and ESIs. Approach: The STEAM network includes the University of New Mexico, New Mexico State University, Northern Arizona University, and Burrell College of Osteopathic Medicine and leverages the unique programs and expertise of these MSIs to collectively train diverse cancer health disparities researchers with interests in serving Native American, Hispanic and rural communities in the Southwestern United States. The ACCEL Program supports excellence, inclusion and transformation of the cancer research science force, expanding and strengthening the pipeline of UR scholars pursuing cancer research. SDSU, a Carnegie Foundation high activity research institution is one of few institutions to be both a Title Ill/Title V eligible institution for diversity. ACCEL works in close collaboration with the University of California San Diego Moores Cancer Center. We will discuss opportunities and approaches employed by each program in support of scholars to increase the number of diverse scholars in these research pipelines and demonstrate the effectiveness of such coordinated efforts. Conclusion: Supporting TCs to focus on scholars within regional programs will prove to be an efficient and effective way to increase recruitment and retention of diverse investigators in NCI research and community programs. Using novel strategies like TCs, the programs will support the attainment of career goals and enhance and diversify workforce capacity across the cancer research and care continuum. Citation Format: Dolores D. Guest, Martha M. Grimes, Andrew L. Sussman, Elizabeth Y. Jimenez, Graciela Unguez, Ahmed Mohammed, Naomi Lee, Jani Ingram, Krystal Charley, Kristin Gosselink, Jill Nery, Avesta Basraki, Natalie Gude, Rebecca Lewison. Enhancing opportunities for underrepresented minorities conducting cancer and cancer health disparities research nationwide: The Transformative Educational Advancement and Mentoring (TEAM) network [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr B121.

Abstract C024: Evaluation of PI3K/AKT/mTOR pathway signaling as a prognostic indicator in Hispanic Mexican women with breast cancer

Abstract Breast cancer (BC) is among the most commonly diagnosed cancer in women and a leading cause of cancer death worldwide. Hispanic/Latina women represent a heterogeneous group with diverse genetic backgrounds, including varying proportions of Native American, European, African and to a lesser extent Asian ancestry. In the US, Hispanic and African American women have lower BC incidence overall yet higher incidence of triple negative breast cancer (TNBC). Furthermore, African American and Hispanic women tend to present with more aggressive disease, at younger ages and worse survival compared to women of European ancestry. These disparities have been attributed to biologic and non-biologic socioeconomic factors. Genomic analyses of Hispanic Mexican (HM) women have revealed specific genetic signatures distinct from those of non-Hispanic women. These variations include AKT kinase mutations activating PI3K/AKT/mTOR signaling pathway and PI3KCA mutations which could potentially benefit from targeted therapies. 4EBP1 phosphorylation by mTORC1 is generally considered a marker of activated mTOR signaling and high levels in tumors associate with worse outcomes in different cancers. To evaluate clinical significance of PI3KCA expression and PI3K/AKT/mTOR signaling, we performed immunohistochemical (IHC) analyses of tissue microarrays (TMA) including 272 BC patient samples from HM women. Protein expression of PI3KCA and p4EBP1 were evaluated quantitatively by receiver operator characteristics (ROC) curves based on area under the curve (AUC) as well as sensibility and specificity. p4EBP1 levels were associated with clinicopathological characteristics. Chi-squared and Fisher’s Exact tests showed higher p4EBP1 expression correlated with estrogen (P=0.001) and progesterone receptor negative BC (P=0.003), TNBC (P<0.001), tumor size (P<0.090), and advanced stage (P<0.001). PI3KCA expression was positively correlated with 4EBP1 expression (P=0.044) as shown by Mann Whitney U tests; but PI3KCA lacked prognostic value after screening through ROC curves. However, uni- and multi-variate Cox regression analyses did show that increased 4EBP1 expression correlates with worse OS. Overall, our study indicates that higher p4EBP1 expression is an independent prognostic factor of worse OS in BC patients. The activation of 4EBP1 may result from several upstream oncogenic alterations or mutations, representing a potential therapeutic target and biomarker. Further research is necessary to better define biological differences in Hispanic women to advance understanding and targeting of health disparities. [Funded by California Breast Cancer Research Program Idea Award B27IB3869, JCCC Breast Cancer Award, Hickey Family Foundation, NCI U54 CA143930, Team Research Grant, UCLA TDG, CIRM DISC2-14166]. Citation Format: Mario Morales Martinez, Giovanny Soca-Chafre, Altagracias Maldonado-Valenzuela, Clara M Rivera-Pazos, Gabriela Antonio-Andres, Mayra Montecillo-Aguado, Georgina Rocha-Lopez, Berenice Alcala-Mota-Velazco, Anel Gomez-Garcia, Madhuri Wadehra1, Richard J Pietras, Sergio Gutierrez-Castro, Sara Huerta-Yepez, Diana Marquez-Garban. Evaluation of PI3K/AKT/mTOR pathway signaling as a prognostic indicator in Hispanic Mexican women with breast cancer [abstract]. In: Proceedings of the 17th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2024 Sep 21-24; Los Angeles, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2024;33(9 Suppl):Abstract nr C024.